Revenio Group Oyj announced that Olli-Pekka Salovaara, Revenio Group Corporation's long-term President & CEO resigned on 31 December 2016. At the same time, he resigned from board membership in the subsidiaries Icare Finland Oy, Revenio Research Oy, Done Medical Oy and Oscare Medical Oy. Timo Hildén, who assumed the position of the Group's new President & CEO on 1 January 2017 and has been a deputy member on the boards of Icare Finland Oy, Revenio Research Oy and Done Medical Oy will become an ordinary member of these boards, and Robin Pulkkinen, the Group's CFO, will be appointed a deputy member of the boards.